Alphagreen Group has been instrumental in funding further research on consumer insights in CBD and wellness. As a globally operating acquisition and incubation platform with a focus on health & wellness, the group scales brands via diverse owned and external distribution channels.
Founded in 2019, Alphagreen Group was born from a passion for health and wellbeing, combined with technology and innovation. The brainchild of entrepreneurs Alexej Pikovsky and Viktor Khliupko, Alphagreen is working to simplify the entire shopper experience across self-care wellness sectors including sleep, pain, and anxiety.
The 2021 survey was conducted with 5000 participants all based throughout the UK. It covers the same ground as research done the year before in order to analysse trends and correlations, and also goes into more detail regarding pain, sleep, and anxiety in relation to CBD usage.
The 2020 survey was conducted with 5000 participants across the UK. Alphagreen wanted to get insights on the general population’s approach to health and wellness in relation to CBD and cannabis, starting with the basics like consumer awareness and knowledge of the products. Alphagreen’s research showed that the main reasons for using CBD are pain management, sleep issues, and anxiety problems.